Table 2
Abnormal karyotypes
| Age | Karyotype | Curative treatment? | CR? | Overall survival (months) |
|---|---|---|---|---|
| CR, complete remission. | ||||
| Standard risk | ||||
| 3 | 47,XY,+21c[4]/48,XY,+11,+21c[6] | Yes | Yes | 42+ |
| 33 | 46,XY,del(9)(q13q22)[8]/46,XY[12] | Yes | Yes | 8 |
| 66 | 46,XY,del(11)(q14-21)[9]/46,XY[1] | Yes | Yes | 49+ |
| 72 | 47,XY,+8[11] | No | No | 8 |
| Poor risk | ||||
| 39 | 46,XX,add(3)(q2?6)[4]/46,idem,-7[6]/46,XX[1] | Yes | No | 18 |
| 39 | 42-45,XY,-3,-5,-7,+8,add(10)(p11-12),der(16)(q22),-17,der(17), t(7;17)(q11;q22-24)[cp10] | Yes | Yes | 7 |
| 45 | 44,XY,-3,-5,-6,del(7)(q2?2),+8,?t(9;9)(p?;p?),-13,-15,del(20)(q1?1),+mar1,+mar2,inc[cp3] | Yes | No | 2 |
| 53 | 42-44,der(1),der(3),der(7),der(16),der(19),inc[7] | Yes | No | 4 |
| 57 | 46,XX,del(5)(q12q31)[2]/44-46,idem,add(1)(q?),-3,add(7)(q?),add(16)(q?), -17,+mar,inc[]/46,XX[] | Yes | No | 0 |
| 61 | 44,XY,der(1)t(1;?16)(p1?;?q10),+del(1)(q1?),del(3)(q2?3q2?6), del(5)(q31q3?5),-7,-16,?del(20)(p1?3)[9] | Yes | No | 0 |
| 64 | 46-54,XY,del(1)(q?),+4,-5,+?6x2,+8,+t(11;?22)(?q10;?q10)x2,-16,-17, t(17;22)(p?10;q?),+19,+idic(22)(q13)x2[cp5]/46,XY[2] | Yes | No | 15 |
| 64 | 45,XX,add(1)(q?42),del(1)(q?32),der(5),der(7),del(7)(p22p15)inv(7)(p15q22),-19[13] | Yes | No | 0 |
| 68 | 46-47,XY,-1,dic(5;7)(q14;q32),der(17)?t(1;17)(p22;q24),add(18)(q2?3),add(19)(p1?),?idic(21)(p1?)?add(22)(p11),+2∼4mar[cp5] | Yes | Yes | 5+ |
| 69 | 44-45,t(1;17)(q?;q?),der(1),add(3)(p?),der(5),add(16)(p?),inc[20]/46,XY[4] | Yes | No | 0 |
| 72 | 40-46,X,der(3)?t(2;3),-5,-5,del(6)(q?),-7,add(18)(q2?),-20,inc[cp9]/46,XX[1] | No | No | 7 |
| 84 | 68-75,XXX,-1,del(1)(p3),del(2)(p?),+del(2)(p?),+3,add(3)(q?),del(6)(q2),+del(6)(q2),add(11)(q23),+?dup(11)(q13q24),+6mar[cp14]/46XX[4] | No | No | 0 |
